What do oncologists need to know about biosimilar products?

Many biologic products have improved the outcomes of cancer patients, but the costs can substantially burden healthcare systems. Biosimilar products can potentially reduce drug costs and increase patient access to beneficial treatments. Approval of a biosimilar product relies on the demonstration of...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, Linda K. S., Mok, Kevin, Liu, Calvin, Chan, Stephen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062853/
https://www.ncbi.nlm.nih.gov/pubmed/27733189
http://dx.doi.org/10.1186/s40880-016-0151-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062853/
https://www.ncbi.nlm.nih.gov/pubmed/27733189
http://dx.doi.org/10.1186/s40880-016-0151-x

Ejemplares similares